Pliant Therapeutics appoints Craig Blanchette as senior vice president, research (siRNA)
PLRX•Pliant Therapeutics appointed Craig Blanchette as senior vice president, research (siRNA). Blanchette joins from Switch Therapeutics, where he most recently served as chief scientific officer, and previously headed protein chemistry at Genentech.
1. Research leadership appointment
Pliant Therapeutics appointed Craig Blanchette as senior vice president, research (siRNA). He joins from Switch Therapeutics, where he most recently served as chief scientific officer; he previously headed protein chemistry at Genentech.
